Skip to content
  1. Home
  2. Medications & hormones
  3. Mesterolone (Proviron)

Mesterolone (Proviron)

An anabolic steroid used clinically to treat male hypogonadism and low testosterone.

Medications & hormones

Research records

Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.

Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.

Mesterolone (Proviron)

An anabolic steroid used clinically to treat male hypogonadism and low testosterone.

Evidence category: Reference only. This describes the source category, not approval or certainty.

Regulatory statement in source: Not separately recorded; do not infer approval from the evidence category.

Mesterolone (Proviron) is an anabolic steroid used clinically to treat low testosterone, hypogonadism, oligozoospermia, and Leydig cell failure. Structurally similar to dihydrotestosterone, it has been used primarily since the early 1960s. Regulatory status varies by country; approval status in the United States is limited.

Benefits reported in the imported source

  • Indicated for treatment of male hypogonadism and associated fertility issues

Risks and limits

  • Weak anabolic activity compared to other steroids
  • Androgenic side effects
  • Cardiac remodelling and lipid profile changes

Source bottom line: Regulatory approval for hypogonadism with weak anabolic properties and potential cardiac effects requiring monitoring.

Uncertainty: Reference information only. Not medical advice.

Study protocols — reports, not instructions

No study protocol recorded in this snapshot. This does not establish that no study exists.

Community and practice descriptions

Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.

Pharmacokinetic context

Historical half-life estimate: 12–13 hours. DrugBank clinical-pharmacology monograph Population/route context and estimates may differ. This is not a schedule or a verified human dosing rule.

Source references

Snapshot provenance

Source ID: catalog:hormone:mesterolone. Commit: adc7684614f9439b41d91a3312b62e7982c7e20e. Review state: historical-not-reverified. Authored links are retained separately from the canonical evidence links in the public data. App templates/defaults and rejected drafts are archived, not deployed.

Related entries and components

None listed.